(Q53408657)

14 May 2018

title

Cost-effectiveness of gastric bypass for severe obesity. (English)

1 reference

14 May 2018

cost-effectiveness analysis

main subject

obesity

0 references

1 reference

Benjamin M Craig

1

1 reference

14 May 2018

Daniel S Tseng

series ordinal

2

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 October 2002

1 reference

14 May 2018

American Journal of Medicine

published in

1 reference

14 May 2018

volume

113

1 reference

14 May 2018

page(s)

491-498

1 reference

14 May 2018

issue

6

1 reference

14 May 2018

A double-blind randomized placebo-controlled trial of sibutramine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Gastric surgery for morbid obesity. The Adelaide Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Results of the surgical treatment of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Safety and long-term efficacy of revisional surgery in severe obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Contributions of obesity and weight loss to gallstone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

A decade of change in obesity surgery. National Bariatric Surgery Registry (NBSR) Contributors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Current practices in the prophylaxis of venous thromboembolism in bariatric surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Lifetime Health and Economic Consequences of Obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients--what have we learned?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

A health status assessment of the impact of weight loss following Roux-en-Y gastric bypass for clinically severe obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901266-4

10.1016/S0002-9343(02)01266-4

7 January 2021

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

12427499

1 reference

14 May 2018